Contact Us
linkedin
twitter
  • ABOUT SSL
    • History
    • Contributors
  • DISCIPLINES
    • Anthropology
    • Economics
    • History
    • Philosophy
    • Political Science
    • Social Psychology
    • Sociology
  • SPECIAL COLLECTIONS
    • Evolving Values for a Capitalist World
    • Frontier Issues in Economic Thought
    • Galbraith Series
    • Global History
  • NEWSLETTER

Bangladesh: A Tough Battle for a National Drug Policy

  1. Home
  2. >>
  3. Political Science
  4. >>
  5. Public Policy
  6. >>
  7. Health
  8. >>
  9. Public Health Policy
  10. >>
  11. Bangladesh: A Tough Battle...
Bangladesh: A Tough Battle for a National Drug Policy
Author(s)Chowdhury, Zafrullah
AbstractWhen on May 29, 1982, the Bangladesh Council of Ministers approved the proposals for a National Drug Policy, the news was a bombshell to those concerned nationally and internationally with pharmaceuticals. Unlike in other countries, where medicinal drug policies have developed gradually over a period of time and may not be found in one single comprehensive document but several, the Bangladesh example reflects the intensive activity of the Expert Committee which worked out the policy, based on 16 criteria, in 15 days. Its Report, almost unchanged, was made law on 12 June. Thirteen years later it can be observed that despite opposition from many actors, such as the national and international pharmaceutical industry with support from some governments in the North, the Bangladesh Medical Association, parts of the Press, and at a later stage, the Bangladesh Government itself, the output of essential drugs has increased from about 30 to about 80 per cent, prices have in almost all cases gone down considerably, the domestic industry has grown rapidly, the quality of its production has increased dramatically, and people’s awareness about medicinal drugs has been steadily growing. The Bangladesh story has been told before and is well known not only to those active in the field of pharmaceuticals but also to the wider circle of concerned citizens in the South and the North who are searching for broad-based, democratic, people-oriented solutions to societal problems. The author of this paper, Dr Zafrullah Chowdhury, has been one of the central actors in the Bangladeshi pharmaceutical industry. In 1972, he set up Gonoshasthaya Kendra (the People’s Health Centre), which initially concentrated on primary health care and the training of paramedics, but later expanded beyond the health sector to include in its work education, nutrition, agriculture, employment generation and women’s emancipation. These activities now serve more than 500,000 people. In 1981, Dr Zafrullah Chowdhury set up Gonoshasthaya Pharmaceuticals in order to manufacture essential drugs of high quality and at low cost.
IssueNo
Pages96-147
ArticleArticle Not Available
SourceDevelopment Dialogue
VolumeNo
PubDate
ISBN_ISSN

Health

  • Biosecurity
  • Public Health Policy


Boston University | ECI | Contact Us

Copyright Notification: The Social Science Library (SSL) is for distribution in a defined set of countries. The complete list may be found here. Free distribution within these countries is encouraged, but copyright law forbids distribution outside of these countries.